Login to Your Account

Doing The Buyout Dance: Ligand Pharma Buzz, More

By Randall Osborne

Monday, January 23, 2006
Last week's agreement between Ligand Pharmaceuticals Inc. and Organon Pharmaceuticals USA Inc. to end their co-promotion deal for the oral morphine product Avinza renewed chatter related to Ligand's takeover prospects - and talk already was active about other potential buyouts, as the pharma industry moves ever more aggressively to beef up its pipelines and capabilities. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription